About this episode

Experts discuss the latest advancements in drug delivery for glaucoma treatment.

I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. Editorially independent content supported with advertising by Glaukos.

Sponsors

Glaukos

More episodes of GT: The Podcast

• Survey Says: Intervention for Controlled Glaucoma · June 26, 2026 · 42 min
• Reflections on Change · February 11, 2026 · 16 min
• The Paul Glaucoma Implant · December 30, 2025 · 10 min
• Glaucoma Intrascleral Tube Surgery · November 21, 2025 · 9 min
• Tube Erosion · October 24, 2025 · 10 min
• Survey Says: Reducing Medication Burden for an Unhappy Patient · October 2, 2025 · 38 min

Explore listener stats, chart rankings, contacts and more on the GT: The Podcast podcast page.